Will Incyte (INCY) Beat Estimates Again in Its Next Earnings Report?

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Incyte (INCY) , which belongs to the Zacks Medical - Biomedical and Genetics industry, could be a great candidate to consider.This specialty drugmaker has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 13.90%.For the last repor ...